Tradestie Institutional Equity Comparison Engine
NVS vs AMGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AMGN Overall Edge
AMGN Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amgen Inc (AMGN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 16.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus AMGN at 18.6x Forward P/E and 34.1% operating margin (+8.5% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against AMGN sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AMGN
NVS 16.2x vs AMGN 18.6x Fwd P/E
Growth & Margin Winner
AMGN
Op Margin 34.0% vs 34.1% ยท YoY +4.7% vs +8.5%
Momentum & Technical Winner
AMGN
1Y +22.5% vs +38.9% ยท 52W Pos 81% vs 90%
Options & Structure Winner
AMGN
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (10th %ile IV)
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap
$302.9B
1M Return
+7.28%
1Y Return
+22.5%
Forward P/E
16.2x
Unified AI Score
41.5 / 100
SELL
Tech 29.0
Fund 38.0
Flow 50.0
Mom 21.1
AMGN
NASDAQ
Amgen Inc
Biological Products, (No Disgnostic Substances)
$466.83
+0.25% 1D
Market Cap
$252.6B
1M Return
+7.94%
1Y Return
+38.94%
Forward P/E
18.6x
Unified AI Score
42.2 / 100
HOLD
Tech 24.0
Fund 50.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NVS +22.5%
AMGN +38.94%
Spread: +16.44 pp (AMGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NVS TTM Op. Margin: 34.0%
AMGN TTM Op. Margin: 34.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs AMGN. Trailing 12-month operating profitability (NVS 34.0% vs AMGN 34.1%) and valuation multiples (NVS 16.2x vs AMGN 18.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NVS | AMGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $302.9B | $252.6B | Larger Scale | NVS |
| Trailing P/E Ratio Valuation | 30.6x | 27.1x | Lower Multiple | AMGN |
| Forward P/E Ratio Valuation | 16.2x | 18.6x | Lower Multiple | NVS |
| Revenue Growth (YoY) Growth | +4.7% | +8.5% | Higher Growth | AMGN |
| Operating Margin (TTM) Profitability | 34.0% | 34.1% | Higher Margin | Tie |
| Net Profit Margin Profitability | 17.5% | 24.1% | Higher Margin | AMGN |
| Return on Equity (ROE) Capital Efficiency | 24.3% | 78.3% | Higher ROE | AMGN |
| 52-Week Range Position Momentum | 81% ($123โ$170) | 90% ($312โ$484) | Stronger Trend | AMGN |
| Beta / 30D Volatility Risk Regime | 0.31ฮฒ ยท 27% Vol | 0.47ฮฒ ยท 26% Vol | Lower Realized Risk | AMGN |
| Unified Institutional Score Composite Signal | 41.5 / 100 (SELL) | 42.2 / 100 (HOLD) | Higher Composite | AMGN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NVS vs AMGN Buy Guide
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
AMGN
CONSOLIDATION
58d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NVS nor AMGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.